The Huntington's Disease Society of America Supports the Medical Research Investment Act

Huntington's Disease Society of America
Tuesday, 27 February 2001

NEW YORK, NY, February 27, 2001 – Today, in a press conference being held on Capitol Hill, several members of Congress are introducing the Medical Research Investment (MRI) Act. The MRI Act would increase limitations on charitable giving for medical research. Through the MRI Act, deductibility limits on these contributions will be extended beyond the current 50 percent of income to 80 percent. The MRI Act will also end the punitive ordinary income tax or alternative minimum tax imposed on those who give away stock from incentive stock options.

The Huntington's Disease Society of America (HDSA) encourages support of the Medical Research Investment Act. The MRI Act will reduce barriers to philanthropy in the tax code, thus allowing for private resources to increase funding to find a cure for Huntington's Disease (HD) and many other debilitating and life-threatening diseases.

Huntington's Disease is an inherited, degenerative brain disorder that results in the progressive loss of control of both the mind and the body. Each child of an affected parent has a 50 percent chance of inheriting the disease. Presently, there is no effective treatment or cure for HD, but with the help of HDSA, there is hope. The Huntington's Disease Society of America is a national non-profit voluntary health agency that is dedicated to finding a cure for HD while providing vital services to those affected by this life-altering disease.

Join us in supporting the Medical Research Investment Act. For more information, please contact your local Congressman or log on to www.congress.gov. You may also contact 1-800-345-HDSA for more information. HDSA is dedicated to making this the last generation with HD.

For more information, or to contact Huntington's Disease Society of America, see their website at: www.hdsa.org